Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Pharmaceutical Contract Manufacturing is estimated at US$112.4 Billion in 2023 and is projected to reach US$159.8 Billion by 2030, growing at a CAGR of 5.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the pharmaceutical contract manufacturing market is driven by several factors, including the rising demand for generic medicines, the increasing complexity of drug production, and the expansion of the biologics market. As patent cliffs lead to increased generic competition, pharmaceutical companies are turning to CMOs to expedite production and capitalize on market opportunities. The complexity of producing new generations of drugs, especially biologics and personalized medicines, also necessitates specialized capabilities that many pharmaceutical firms find more feasible to outsource.
Additionally, the shift towards personalized medicine is pushing companies to adapt to flexible and scalable production processes, which contract manufacturers are equipped to handle. These trends, combined with the global push for cost efficiency and faster time-to-market, continue to drive significant growth in this sector, highlighting its critical role in the pharmaceutical industry's supply chain.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Pharmaceutical Contract Manufacturing Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Pharmaceutical Contract Manufacturing Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the API/Bulk Drugs segment, which is expected to reach US$94.8 Billion by 2030 with a CAGR of a 4.9%. The Advanced Drug Delivery Formulations segment is also set to grow at 4.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $33.9 Billion in 2023, and China, forecasted to grow at an impressive 6.4% CAGR to reach $27.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AbbVie Inc., Aenova Holding GmbH, Catalent Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 528 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $112.4 Billion |
| Forecasted Market Value (USD) by 2030 | $159.8 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Pharmaceutical Contract Manufacturing - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Recent Market Activity
MARKET TRENDS & DRIVERS
- Strong Rise in Pharmaceutical Sales to Drive Demand for Pharmaceutical Contract Manufacturing
- Global Prescription Drug Sales (In US$ Billion) for the Years 2017, 2019, 2021, 2023 & 2025
- Emergence of Outsourcing Trend Bodes Well for CDMOs
- Pharmaceutical Contract Manufacturers Adopt Advanced Manufacturing Technologies
- Embracing Emerging Technologies
- Exploring & Exploiting New Technologies for Rich Dividends
- Rapid Growth of Generic Drugs Drives Demand for Pharma Contract Manufacturing
- Global Generic Drugs Market Size (in $ Billion) for the Years 2016, 2019, 2020 & 2025
- Increasing Significance of Biologic Drugs Fuels Innovations Supports Demand for Pharmaceutical Contract Manufacturing Market
- Global Biologic Drugs Market Size (in US$ Billion) for the Years 2019, 2022 & 2025
- Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth
- Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
- Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
- World Diabetes and Population Statistics (2019, 2030 & 2045)
- Persistent Increase in Pharmaceutical R&D Bodes Well for PCM
- Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
- Increasing Sales of OTC Drugs Presents an Opportunity for Pharma Contract Manufacturing Market
- Increasing Outsourcing of Clinical Trials to Emerging Markets
- New Technology Promises to Improve Sterile Manufacturing Process
- Serialization Drives New Design Developments in Pharma Sector
FOCUS ON SELECT PLAYERS (Total 192 Featured)
- AbbVie Inc.
- Aenova Holding GmbH
- Catalent Inc.
- Enteris BioPharma, Inc.
- Jubilant Pharma Ltd.
- Kemwell Biopharma Pvt. Ltd.
- Lifecore Biomedical
- Lonza Group Ltd.
- Thermo Fisher Scientific, Inc.
- WuXi AppTec Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/fk9xlc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
